CellTech's Delsym for children, introduced to the cough syrup market category less than a year ago, ranked as the No. 1 selling pediatric cough syrup for the 20-week period ended Jan. 25, according to Information Resources Inc. data. Delsym is the only single-ingredient (dextromethorphan) cough syrup with 12-hour extended-release efficacy, which makes it a favorite of physicians, pharmacists and ultra-loyal customers, according to the company.
According to IRI reports, the Delsym brand continues to gain significant acceptance in the OTC cough syrup market category, and its three SKUs are responsible for more than 25 percent of the category's growth.
[ILLUSTRATION OMITTED]
COPYRIGHT 2004 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2004 Gale Group
Contact
Home
A
Dacarbazine